UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

Psychopharmacology, 2018-07, Vol.235 (7), p.1923-1932

2018

Volltextzugriff (PDF)

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

Neurotherapeutics, 2021-01, Vol.18 (1), p.534-543

2021

Volltextzugriff (PDF)

The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity

Neuropsychopharmacology (New York, N.Y.), 2013-12, Vol.38 (13), p.2613-2622

2013

Volltextzugriff (PDF)

Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders

Frontiers in psychiatry, 2022-02, Vol.13, p.837757-837757

2022

Volltextzugriff (PDF)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

Frontiers in pharmacology, 2018-03, Vol.9, p.177-177

2018

Volltextzugriff (PDF)

Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia

Schizophrenia research, 2018-01, Vol.191, p.87-94

2018

Volltextzugriff (PDF)

Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans

Neuropharmacology, 2018-06, Vol.135, p.412-423

2018

Volltextzugriff (PDF)

Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study

Neuropsychopharmacology (New York, N.Y.), 2013-02, Vol.38 (3), p.492-503

2013

Volltextzugriff (PDF)

Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS?

Schizophrenia research, 2018-05, Vol.195, p.455-462

2018

Volltextzugriff (PDF)

In vivo evidence of lower synaptic vesicle density in schizophrenia

Molecular psychiatry, 2021-12, Vol.26 (12), p.7690-7698

2021

Volltextzugriff (PDF)

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms

Journal of psychopharmacology (Oxford), 2023-07, Vol.37 (7), p.687-697

2023

Volltextzugriff (PDF)

Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study

The journal of clinical psychiatry, 2010-11, Vol.71 (11), p.1475

2010

Volltextzugriff (PDF)

The Psychiatric Consequences of Cannabinoids

Clinical therapeutics, 2018-09, Vol.40 (9), p.1448-1456

2018

Volltextzugriff (PDF)

Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis

Psychopharmacology, 2019-09, Vol.236 (9), p.2635-2640

2019

Volltextzugriff (PDF)

Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia

The world journal of biological psychiatry, 2022-01, Vol.23 (1), p.33-45

2022

Volltextzugriff (PDF)

A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants

Neuropsychopharmacology (New York, N.Y.), 2021-01, Vol.46 (2), p.478-485

2021

Volltextzugriff (PDF)

Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial

Headache, 2022-11, Vol.62 (10), p.1383-1394

2022

Volltextzugriff (PDF)

Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans

Scientific reports, 2020-02, Vol.10 (1), p.3450, Article 3450

2020

Volltextzugriff (PDF)

Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans

Psychopharmacology, 2019-11, Vol.236 (11), p.3209-3219

2019

Volltextzugriff (PDF)

Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial

Journal of the neurological sciences, 2024-05, Vol.460, p.122993-122993, Article 122993

2024

Volltextzugriff (PDF)

In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers

Psychopharmacology, 2020-10, Vol.237 (10), p.3097-3107

2020

Volltextzugriff (PDF)

Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?

Cannabis and cannabinoid research, 2022-12, Vol.7 (6), p.898

2022

Volltextzugriff (PDF)

The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans

Journal of psychopharmacology (Oxford), 2018-12, Vol.32 (12), p.1308-1318

2018

Volltextzugriff (PDF)

Glutamatergic Modulation of Auditory Information Processing in the Human Brain

Biological psychiatry (1969), 2012-06, Vol.71 (11), p.969-977

2012

Volltextzugriff (PDF)

Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2006-12, Vol.31 (12), p.2767-2775

2006

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(69)
Humans
(57)
Psychiatry
(47)
Male
(42)
Adult
(37)
Female
(35)
Neurosciences & Neurology
(33)
Neurosciences
(31)
Schizophrenia
(25)
Pharmacology & Pharmacy
(23)
Double-Blind Method
(21)
Middle Aged
(21)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Psychosis
(16)
Young Adult
(16)
Cannabis
(14)
Psychology. Psychoanalysis. Psychiatry
(13)
Psychopathology. Psychiatry
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity

Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia

Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans

Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study

Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS?

In vivo evidence of lower synaptic vesicle density in schizophrenia

Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms

Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study

The Psychiatric Consequences of Cannabinoids

Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis

Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia

A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants

Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial

Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans

Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans

Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial

In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers

Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?

The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans

Glutamatergic Modulation of Auditory Information Processing in the Human Brain

Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia

Suchergebnisse filtern